by Peter Ciszewski | May 17, 2019
Prof. Arndt Rolfs, MD, Chief Executive Officer at Centogene discuses his company’s role in identiying rare diseases. In this video, Dr. Rolfs says that his company has the industry’s largest diagnostic potfolio. However, since genetics is constantly...
by Peter Ciszewski | May 16, 2019
Malissa J. Wood, MD, is co-director of the Corrigan Women’s Heart Health Program at the Massachusetts General Hospital Heart Center and associate professor of medicine at Harvard Medical School. In this video, Dr. Wood provides an overview of spontaneous...
by Peter Ciszewski | May 16, 2019
The FDA’s Oncologic Drugs Advisory Committee (ODAC) voted 12-3 that the benefits of pexidartinib outweigh the risks for the treatment of adults with tenosynovial giant cell tumor (TGCT) not amenable to surgical resection. If approved, pexidartinib (Daiichi Sankyo) — a...
by Peter Ciszewski | May 14, 2019
Kristen Wheeden, Director of Development for the American Porphyria Foundation, discusses some of the challenges in diagnosing this rare disease. Typically, porphyria is diagnosed through blood, urine, and stool tests, especially at or near the time of...
by Peter Ciszewski | May 13, 2019
Jeffrey W Olin, DO, Professor of Medicine at the Icahn School of Medicine at Mount Sinai, discusses diagnosing and treating fibromuscular dysplasia (FMD), a rare condition characterized by abnormal development or growth of cells in the walls of blood vessels...
